Product Images Quetiapine Extended-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Quetiapine Extended-release NDC 69948-002 by Alignscience Pharma Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
7366858f 2734 4214 a5ba 66307182fd62 150mg500s
7366858f 2734 4214 a5ba 66307182fd62 150mg60s
This is a medication called Quetiapine in its extended-release tablet form, which is only available under prescription. Each extended-release tablet contains 172.7 mg of quetiapine fumarate. It is used to treat certain mental/mood disorders. The recommended dosage is one tablet of 150 mg once a day. The medication guide should be given to each patient. Keep the medicine out of the reach of the children. It is advised to store this medication at 25°C with excursions being permitted to 15°t0 30° C. The manufacturer of the medication is AlignScience Pharma Inc., while the tablets are manufactured by Haimen Pharma Inc.*
7366858f 2734 4214 a5ba 66307182fd62 200mg500s
This is a description of Quetiapine Extended-Release Tablets, USP, with a dosage of 200mg and comes with a medication guide for each patient. The tablets should be swallowed whole and not split, crushed or chewed. They are usually taken once daily, and the accompanying prescribing information must be consulted. It is a warning that the medication should be kept out of children's reach, and they should be stored at 25°C (77°F), with excursions to 15°to 30°C (59° to 86°F). The tablets are manufactured by Haimen Pharma Inc. and distributed by AlignScience Pharma Inc.*
7366858f 2734 4214 a5ba 66307182fd62 200mg60s
This is a description of a medication called Quetiapine Fumarate, with an NDG number of 69948-003-03, that comes in an extended-release tablet form containing 230.3 mg of the active ingredient. The medication is to be taken once daily and should not be crushed, split or chewed. The prescription document accompanying the medication has specific information on dosage and additional warnings, such as the need to keep out of reach of children. The medication is manufactured in Jiangsu, China, by Haimen Pharma Inc.*
7366858f 2734 4214 a5ba 66307182fd62 chemical structure
7366858f 2734 4214 a5ba 66307182fd62 figure 1
7366858f 2734 4214 a5ba 66307182fd62 figure 2
7366858f 2734 4214 a5ba 66307182fd62 figure 3
The text provided appears to be a graph showing the proportion of patients with relapse over time. The graph indicates that at week 0, 100% of patients experienced relapse. The x-axis (horizontal) is labeled "Time (weeks)" and the y-axis (vertical) is labeled "Proportion of Patients with Relapse (%)". The title of the graph reads "Relapse" with a line below it that appears to read "——= areruvaL" and "PLas LwAL".*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.